NHIQ Stock Overview
Operates as a healthcare IT company in the United States, Canada, and the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
NantHealth, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$2.17 |
| 52 Week Low | US$0.000001 |
| Beta | 1.42 |
| 1 Month Change | -95.00% |
| 3 Month Change | -99.50% |
| 1 Year Change | -99.97% |
| 3 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Investors Aren't Buying NantHealth, Inc.'s (NASDAQ:NH) Revenues
Apr 17
NantHealth GAAP EPS of -$0.11, revenue of $16.5M
Aug 04Ronald Louks Is The Chief Operating Officer of NantHealth, Inc. (NASDAQ:NH) And They Just Sold 26% Of Their Shares
Mar 18Time To Worry? Analysts Are Downgrading Their NantHealth, Inc. (NASDAQ:NH) Outlook
Mar 06If You Had Bought NantHealth (NASDAQ:NH) Shares A Year Ago You'd Have Earned 183% Returns
Feb 04
NantHealth jumps after study highlights the utility of its decision-support platform
Dec 11Shareholder Returns
| NHIQ | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | 0.6% | -2.2% |
| 1Y | -100.0% | 2.2% | 23.9% |
Return vs Industry: NHIQ underperformed the US Healthcare Services industry which returned 2.2% over the past year.
Return vs Market: NHIQ underperformed the US Market which returned 23.4% over the past year.
Price Volatility
| NHIQ volatility | |
|---|---|
| NHIQ Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 9.4% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NHIQ's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine NHIQ's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 373 | Rao Naseem | nanthealth.com |
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform’s comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans, and centers for medicare and medicaid services for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks.
NantHealth, Inc. Fundamentals Summary
| NHIQ fundamental statistics | |
|---|---|
| Market cap | US$3.26k |
| Earnings (TTM) | -US$70.37m |
| Revenue (TTM) | US$64.27m |
0.0x
P/S Ratio0.0x
P/E RatioIs NHIQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NHIQ income statement (TTM) | |
|---|---|
| Revenue | US$64.27m |
| Cost of Revenue | US$23.37m |
| Gross Profit | US$40.90m |
| Other Expenses | US$111.28m |
| Earnings | -US$70.37m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.16 |
| Gross Margin | 63.64% |
| Net Profit Margin | -109.49% |
| Debt/Equity Ratio | -108.8% |
How did NHIQ perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 16:47 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2023/09/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NantHealth, Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Richard Close | Canaccord Genuity |
| Steven Halper | Cantor Fitzgerald & Co. |
| Steven Halper | FBR Capital Markets & Co. |